Extracellular matrix heparin-binding domains

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9540428
APP PUB NO 20140011978A1
SERIAL NO

13933448

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Heparin binding peptides derived from a Tenascin (TNC) III1-5 domain or a fibrinogen β15-66 domain have been found that bind certain cytokines with high affinity. Materials and methods for making compositions and devices using these peptides are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)LAUSANNE LAUSANNE VAUD

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, Laporte Laura De Pinte, BE 4 40
Hubbell, Jeffrey A Preverenges, CH 173 9467
Martino, Mikael Nyon, CH 4 4
Rice, Jeffrey J Port Salerno, US 1 7
Tortelli, Federico Lausanne, CH 2 20

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 10, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00